Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Link opens in a new tab
English
Español
Search content at University of Kentucky
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Biliverdin reductase and bilirubin in hepatic disease
Lauren Weaver
, Abdul Rizaq Hamoud
, David E. Stec
,
Terry D. Hinds
Pharmacology and Nutritional Sciences
Cardiovascular Research Priority Area
Center for Computational Sciences
Diabetes & Obesity Research Priority Area
Markey Cancer Center / Cancer Research Priority Initiative
Molecular and Cellular Oncology Research Program
Substance Use Priority Research Area
Research output
:
Contribution to journal
›
Review article
›
peer-review
95
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Biliverdin reductase and bilirubin in hepatic disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Fatty Liver
100%
Liver Disease
100%
Oxidoreductase
100%
Bilirubin
100%
Biliverdin
100%
Nonalcoholic Fatty Liver
50%
Antioxidant
25%
Alcohol Consumption
25%
Hepatocellular Carcinoma
25%
Lipid Storage
25%
Liver Cirrhosis
25%
Liver Fibrosis
25%
Steatosis
25%
Heme
25%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Disease
100%
Oxidoreductase
100%
Fatty Liver
100%
Bilirubin
100%
Biliverdin
100%
Nonalcoholic Fatty Liver
50%
Liver Cell Carcinoma
25%
Steatosis
25%
Liver Cirrhosis
25%
Liver Fibrosis
25%
Antioxidant
25%
Heme
25%
Biochemistry, Genetics and Molecular Biology
Biliverdin Reductase
100%
Bilirubin
100%
Enzyme
33%
Lipid Storage
33%